 Individuals with the rapid phenotype of either CYP1A2 or NAT2 metabolize PhIP more effectively and are therefore at greater risk of PhIP's carcinogenic metabolite and could be at a higher risk of cancer.Rats were fed PhIP at concentrations of 25, 100, and 200 ppm.The rats gained weight throughout the experiment, but feeding concentration of PhIP remained constant.